US Stock MarketDetailed Quotes

Abbott Laboratories (ABT)

Watchlist
  • 95.470
  • -6.090-6.00%
Close Apr 16 15:59 ET
  • 95.400
  • -0.070-0.07%
Post 19:59 ET
166.28BMarket Cap26.74P/E (TTM)

Abbott Laboratories (ABT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
11.78%9.57B
15.59%3.32B
3.03%2.79B
4.44%2.05B
38.24%1.42B
17.86%8.56B
-5.60%2.87B
44.11%2.71B
62.93%1.96B
-10.32%1.03B
Net income from continuing operations
-51.32%6.52B
-80.76%1.78B
-0.12%1.64B
36.64%1.78B
8.16%1.33B
134.18%13.4B
478.98%9.23B
14.62%1.65B
-5.31%1.3B
-7.06%1.23B
Operating gains losses
-86.51%65M
----
----
----
----
282.54%482M
----
----
----
----
Depreciation and amortization
-3.17%3.12B
-1.86%792M
-1.25%791M
-3.48%777M
-6.09%756M
-0.77%3.22B
-0.74%807M
-2.79%801M
0.63%805M
-0.12%805M
Other non cash items
----
----
1,104.55%221M
-274.29%-244M
41.71%-436M
----
----
87.71%-22M
121.21%140M
30.48%-748M
Change In working capital
91.29%-803M
101.31%110M
-93.25%11M
4.91%-407M
7.84%-517M
-272.40%-9.22B
-450.59%-8.39B
150.78%163M
3.60%-428M
-201.61%-561M
-Change in receivables
5.64%-652M
240.51%222M
-254.39%-202M
-26.15%-410M
-73.51%-262M
-94.10%-691M
-332.35%-158M
87.64%-57M
-65.82%-325M
-164.81%-151M
-Change in inventory
436.21%195M
-0.43%234M
-3.18%213M
102.91%3M
37.80%-255M
75.00%-58M
-20.34%235M
57.14%220M
58.47%-103M
2.15%-410M
-Change in prepaid assets
-62.69%-1.3B
----
----
----
----
-46.86%-796M
----
----
----
----
-Change in payables and accrued expense
112.37%949M
----
----
----
----
-470.41%-7.67B
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
11.78%9.57B
15.59%3.32B
3.03%2.79B
4.44%2.05B
38.24%1.42B
17.86%8.56B
-5.60%2.87B
44.11%2.71B
62.93%1.96B
-10.32%1.03B
Investing cash flow
Cash flow from continuing investing activities
-3.59%-2.42B
-5.43%-913M
23.06%-457M
-28.48%-582M
-10.59%-470M
25.38%-2.34B
-5.10%-866M
6.31%-594M
62.65%-453M
8.01%-425M
Net PPE purchase and sale
1.63%-2.17B
4.31%-689M
10.79%-496M
5.82%-502M
-21.61%-484M
-0.23%-2.21B
4.64%-720M
0.71%-556M
-5.13%-533M
-4.74%-398M
Net business purchase and sale
-10,600.00%-105M
---20M
---55M
----
----
100.12%1M
--0
--0
----
----
Net investment purchase and sale
-16.31%-164M
-40.00%-210M
325.00%90M
-167.53%-52M
128.57%8M
-21.55%-141M
-111.27%-150M
-5.26%-40M
-2.53%77M
67.44%-28M
Net other investing changes
100.00%18M
50.00%6M
100.00%4M
0.00%2M
500.00%6M
-59.09%9M
100.00%4M
-86.67%2M
100.00%2M
-75.00%1M
Cash from discontinued investing activities
Investing cash flow
-3.59%-2.42B
-5.43%-913M
23.06%-457M
-28.48%-582M
-10.59%-470M
25.38%-2.34B
-5.10%-866M
6.31%-594M
62.65%-453M
8.01%-425M
Financing cash flow
Cash flow from continuing financing activities
-16.75%-6.31B
24.93%-1.4B
-11.68%-1.76B
-38.69%-1.1B
-74.74%-2.06B
23.79%-5.4B
9.31%-1.86B
32.65%-1.58B
38.63%-791M
16.60%-1.18B
Net issuance payments of debt
-200.56%-1.61B
88.58%-70M
-1,246.51%-493M
-109.38%-15M
-715.75%-1.04B
78.30%-537M
34.72%-613M
102.86%43M
1,233.33%160M
-202.38%-127M
Net common stock issuance
31.04%-893M
4.13%-302M
59.39%-305M
-100.00%-6M
-23.89%-280M
-5.54%-1.3B
-21.62%-315M
-37,450.00%-751M
99.30%-3M
58.15%-226M
Cash dividends paid
-7.30%-4.12B
-7.52%-1.03B
-7.40%-1.03B
-7.08%-1.03B
-7.21%-1.03B
-7.87%-3.84B
-7.88%-958M
-8.11%-960M
-7.98%-961M
-7.53%-957M
Proceeds from stock option exercised by employees
50.00%396M
-80.00%5M
-25.00%69M
169.23%35M
114.18%287M
58.08%264M
-26.47%25M
64.29%92M
-13.33%13M
116.13%134M
Net other financing activities
---82M
--0
--0
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
-16.75%-6.31B
24.93%-1.4B
-11.68%-1.76B
-38.69%-1.1B
-74.74%-2.06B
23.79%-5.4B
9.31%-1.86B
32.65%-1.58B
38.63%-791M
16.60%-1.18B
Net cash flow
Beginning cash position
10.44%7.62B
-0.62%7.51B
-0.52%6.95B
3.95%6.53B
10.44%7.62B
-30.22%6.9B
12.65%7.56B
-10.82%6.99B
-31.40%6.28B
-30.22%6.9B
Current changes in cash
2.33%835M
612.77%1.01B
6.54%570M
-48.60%368M
-92.36%-1.11B
127.54%816M
-12.96%141M
148.77%535M
155.12%716M
20.99%-576M
Effect of exchange rate changes
173.96%71M
107.23%6M
-127.78%-10M
492.31%51M
166.67%24M
-317.39%-96M
-432.00%-83M
224.14%36M
51.85%-13M
-550.00%-36M
End cash Position
11.90%8.52B
11.90%8.52B
-0.62%7.51B
-0.52%6.95B
3.95%6.53B
10.44%7.62B
10.44%7.62B
12.65%7.56B
-10.82%6.99B
-31.40%6.28B
Free cash flow
16.44%7.4B
22.25%2.63B
6.61%2.29B
8.27%1.55B
48.80%933M
25.54%6.35B
-5.91%2.15B
63.17%2.15B
105.03%1.43B
-17.82%627M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 11.78%9.57B15.59%3.32B3.03%2.79B4.44%2.05B38.24%1.42B17.86%8.56B-5.60%2.87B44.11%2.71B62.93%1.96B-10.32%1.03B
Net income from continuing operations -51.32%6.52B-80.76%1.78B-0.12%1.64B36.64%1.78B8.16%1.33B134.18%13.4B478.98%9.23B14.62%1.65B-5.31%1.3B-7.06%1.23B
Operating gains losses -86.51%65M----------------282.54%482M----------------
Depreciation and amortization -3.17%3.12B-1.86%792M-1.25%791M-3.48%777M-6.09%756M-0.77%3.22B-0.74%807M-2.79%801M0.63%805M-0.12%805M
Other non cash items --------1,104.55%221M-274.29%-244M41.71%-436M--------87.71%-22M121.21%140M30.48%-748M
Change In working capital 91.29%-803M101.31%110M-93.25%11M4.91%-407M7.84%-517M-272.40%-9.22B-450.59%-8.39B150.78%163M3.60%-428M-201.61%-561M
-Change in receivables 5.64%-652M240.51%222M-254.39%-202M-26.15%-410M-73.51%-262M-94.10%-691M-332.35%-158M87.64%-57M-65.82%-325M-164.81%-151M
-Change in inventory 436.21%195M-0.43%234M-3.18%213M102.91%3M37.80%-255M75.00%-58M-20.34%235M57.14%220M58.47%-103M2.15%-410M
-Change in prepaid assets -62.69%-1.3B-----------------46.86%-796M----------------
-Change in payables and accrued expense 112.37%949M-----------------470.41%-7.67B----------------
Cash from discontinued investing activities
Operating cash flow 11.78%9.57B15.59%3.32B3.03%2.79B4.44%2.05B38.24%1.42B17.86%8.56B-5.60%2.87B44.11%2.71B62.93%1.96B-10.32%1.03B
Investing cash flow
Cash flow from continuing investing activities -3.59%-2.42B-5.43%-913M23.06%-457M-28.48%-582M-10.59%-470M25.38%-2.34B-5.10%-866M6.31%-594M62.65%-453M8.01%-425M
Net PPE purchase and sale 1.63%-2.17B4.31%-689M10.79%-496M5.82%-502M-21.61%-484M-0.23%-2.21B4.64%-720M0.71%-556M-5.13%-533M-4.74%-398M
Net business purchase and sale -10,600.00%-105M---20M---55M--------100.12%1M--0--0--------
Net investment purchase and sale -16.31%-164M-40.00%-210M325.00%90M-167.53%-52M128.57%8M-21.55%-141M-111.27%-150M-5.26%-40M-2.53%77M67.44%-28M
Net other investing changes 100.00%18M50.00%6M100.00%4M0.00%2M500.00%6M-59.09%9M100.00%4M-86.67%2M100.00%2M-75.00%1M
Cash from discontinued investing activities
Investing cash flow -3.59%-2.42B-5.43%-913M23.06%-457M-28.48%-582M-10.59%-470M25.38%-2.34B-5.10%-866M6.31%-594M62.65%-453M8.01%-425M
Financing cash flow
Cash flow from continuing financing activities -16.75%-6.31B24.93%-1.4B-11.68%-1.76B-38.69%-1.1B-74.74%-2.06B23.79%-5.4B9.31%-1.86B32.65%-1.58B38.63%-791M16.60%-1.18B
Net issuance payments of debt -200.56%-1.61B88.58%-70M-1,246.51%-493M-109.38%-15M-715.75%-1.04B78.30%-537M34.72%-613M102.86%43M1,233.33%160M-202.38%-127M
Net common stock issuance 31.04%-893M4.13%-302M59.39%-305M-100.00%-6M-23.89%-280M-5.54%-1.3B-21.62%-315M-37,450.00%-751M99.30%-3M58.15%-226M
Cash dividends paid -7.30%-4.12B-7.52%-1.03B-7.40%-1.03B-7.08%-1.03B-7.21%-1.03B-7.87%-3.84B-7.88%-958M-8.11%-960M-7.98%-961M-7.53%-957M
Proceeds from stock option exercised by employees 50.00%396M-80.00%5M-25.00%69M169.23%35M114.18%287M58.08%264M-26.47%25M64.29%92M-13.33%13M116.13%134M
Net other financing activities ---82M--0--0----------------------------
Cash from discontinued financing activities
Financing cash flow -16.75%-6.31B24.93%-1.4B-11.68%-1.76B-38.69%-1.1B-74.74%-2.06B23.79%-5.4B9.31%-1.86B32.65%-1.58B38.63%-791M16.60%-1.18B
Net cash flow
Beginning cash position 10.44%7.62B-0.62%7.51B-0.52%6.95B3.95%6.53B10.44%7.62B-30.22%6.9B12.65%7.56B-10.82%6.99B-31.40%6.28B-30.22%6.9B
Current changes in cash 2.33%835M612.77%1.01B6.54%570M-48.60%368M-92.36%-1.11B127.54%816M-12.96%141M148.77%535M155.12%716M20.99%-576M
Effect of exchange rate changes 173.96%71M107.23%6M-127.78%-10M492.31%51M166.67%24M-317.39%-96M-432.00%-83M224.14%36M51.85%-13M-550.00%-36M
End cash Position 11.90%8.52B11.90%8.52B-0.62%7.51B-0.52%6.95B3.95%6.53B10.44%7.62B10.44%7.62B12.65%7.56B-10.82%6.99B-31.40%6.28B
Free cash flow 16.44%7.4B22.25%2.63B6.61%2.29B8.27%1.55B48.80%933M25.54%6.35B-5.91%2.15B63.17%2.15B105.03%1.43B-17.82%627M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! On the 16th, US President Trump stated that the next round of talks between the US and Show More